Registration number
Title
Registration
Status
Date last updated
Country
Study design
Participants
Intervention
Control
Relevant outcomes
Time- points
NCT04855578 Deprescription of Gabapentinoids in Medical Inpatients (GABA-WHY) 19th April 2021 Recruiting 12th April 2022 Canada Non-RCT Inpatients ≥60 years who have a gabapentinoid prescription prior to admission. In-hospital patient educational brochure Physician education about gabapentinoid prescriptions Usual care Cessation or dose reduction, QoL, pain intensity, initiation of new pain medication At study enrolment, 8 weeks post-discharge
NCT00647322 The impact of reducing overtreatment on quality of life in children with refractory epilepsy 26th March 2008 Unknown 31st March 2008 United Kingdom Non-RCT Patients 6 to 21 years with intractable epilepsy receiving antiepileptic drug polytherapy Reduction of anti-epileptic medications Usual care Dose reduction, QoL At study enrolment and 6 months after entering the study
­­ ACTRN12618000729224 Deprescribing anticholinergic and sedative medications in older people - a randomised controlled trial 2nd May 2018 Recruitment completed. Last follow-up completed 03/06/2021 3rd December 2021 New Zealand RCT Patients ≥60 years, prescribed at least one anticholinergic or sedative medication in the last year and currently undergoing or have had an InterRAI assessment in the previous 12 months. Pharmacist-led comprehensive medication review Usual care Dose reduction, medication use, mortality 6 months after randomisation, 3 and 6 months after trial ends